Vistagen Therapeutics, Inc. (VTGN)
0.2388
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 14:57
Vistagen Therapeutics Price : 0.2388 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 0.2416 | 0.2464 | 0.23 | 0.2355 | 801742.0 |
| Sep 08, 2026 | 0.25 | 0.25 | 0.24 | 0.2434 | 321446.0 |
| Sep 04, 2026 | 0.2462 | 0.2584 | 0.2425 | 0.2428 | 347258.0 |
| Sep 03, 2026 | 0.2513 | 0.2550 | 0.2412 | 0.2462 | 256580.0 |
| Sep 02, 2026 | 0.24 | 0.2539 | 0.24 | 0.246 | 197890.0 |
| Sep 01, 2026 | 0.2473 | 0.2514 | 0.24 | 0.2433 | 596322.0 |
| Aug 31, 2026 | 0.258 | 0.2600 | 0.2434 | 0.255 | 467376.0 |
| Aug 28, 2026 | 0.2569 | 0.2589 | 0.246 | 0.2529 | 449671.0 |
| Aug 27, 2026 | 0.2599 | 0.269 | 0.2529 | 0.257 | 341224.0 |
| Aug 26, 2026 | 0.2515 | 0.269 | 0.2421 | 0.26 | 569365.0 |
| Aug 25, 2026 | 0.245 | 0.252 | 0.2401 | 0.2484 | 712915.0 |
| Aug 24, 2026 | 0.2394 | 0.2481 | 0.2355 | 0.2438 | 477881.0 |
| Aug 21, 2026 | 0.239 | 0.2542 | 0.2367 | 0.244 | 990777.0 |
| Aug 20, 2026 | 0.2461 | 0.249 | 0.233 | 0.2411 | 705687.0 |
| Aug 19, 2026 | 0.2456 | 0.2520 | 0.237 | 0.2441 | 404918.0 |
| Aug 18, 2026 | 0.2535 | 0.2673 | 0.2415 | 0.242 | 2.299M |
| Aug 17, 2026 | 0.27 | 0.27 | 0.2573 | 0.26 | 1.035M |
| Aug 14, 2026 | 0.27 | 0.2744 | 0.26 | 0.2676 | 913218.0 |
| Aug 13, 2026 | 0.2614 | 0.27 | 0.2592 | 0.2663 | 303952.0 |
| Aug 12, 2026 | 0.2659 | 0.2683 | 0.2559 | 0.2612 | 759072.0 |
| Aug 11, 2026 | 0.2674 | 0.2764 | 0.2511 | 0.2691 | 1.222M |
| Aug 10, 2026 | 0.2939 | 0.30 | 0.26 | 0.2638 | 2.386M |
| Aug 07, 2026 | 0.2872 | 0.31 | 0.282 | 0.2876 | 2.556M |
| Aug 06, 2026 | 0.297 | 0.3073 | 0.275 | 0.2838 | 3.574M |
| Aug 05, 2026 | 0.2702 | 0.2988 | 0.266 | 0.297 | 5.544M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.61 |
| Alnylam Pharmaceuticals, Inc. | 248.36 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.275 |
| Vericel Corp. | 37.84 |
Price Related Metrics
| PS Ratio | 3.832 |
| Price to Book Value | 0.4329 |
| Earnings Yield | -713.9% |
| Market Cap | 10.60M |